IX vs NMR
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 11, 2026
IX
NMR
Investment Advisor Scores
NMR
AI Analyst Insights
Detailed Metrics Comparison
| Metric | IX | NMR | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 14.245 | 15.3846 | IX |
| PEG Ratio | 2.7166 | 0.8146 | NMR |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 17.4% | 31.2% | NMR |
| Earnings Growth | 170.6% | 42.0% | IX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 56.2/100 | 37.3/100 | IX |
| Profit Margin | 17.9% | 17.3% | IX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | SELL | IX |
Relative Price Performance (Last 90 Days)
Current Technical Phase
IX
NeutralMixed signals - no dominant trend phase, RSI 54
NMR
MarkupPrice above SMA50, rising 50-day trend (5.9% over 20 days), RSI 71
Fundamentals Snapshot
| Metric | IX | NMR |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 14.8 | 14.6 |
| Trailing P/E | 10.7 | 12.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.3% |
| Gross Margin | 0.4% | 0.8% |
| Operating Margin | 0.2% | 0.3% |
| EPS | 3.66 | 0.87 |
| Dividend Yield | 0.03% | 0.03% |